REGENERON IRELAND DESIGNATED ACTIVITY COMPANY (DAC)

Italy

All drugs from this manufacturer

  • LIBTAYO

    It is an anticancer drug used in adults to treat certain types of skin cancer (advanced squamous cell carcinoma of the skin and advanced basal cell carcinoma), advanced non-small cell lung cancer, and cervical cancer that has worsened during or after chemotherapy. It is also used to prevent the recurrence of squamous cell carcinoma of the skin after surgery.

    Dosage form: solution for infusion, concentrate

    Active substance Dosage
    cemiplimab -

    ATC: L01FF06

  • LYNOZYFIC

    It is an anticancer drug used in adults to treat a type of bone marrow cancer called multiple myeloma, in patients who have already received at least three previous treatments and whose cancer has worsened.

    Dosage form: solution for infusion, concentrate

    Active substance Dosage
    linvoseltamab -

    ATC: L01FX

  • ORDSPONO

    Ordspono is an anticancer drug used in adults to treat two types of blood cancers: follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL), in patients who have already tried at least two previous treatments without success or who have experienced a relapse.

    Dosage form: solution for infusion, concentrate

    Active substance Dosage
    odronextamab -

    ATC: L01FX